Jesse Moore
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Project Manager
Also affiliated: University of Mississippi (1999); Indiana State University (1999–2012)
Staff Researcher
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Jesse Moore's research focuses on adapting and increasing the use of long-acting injectable (LAI) antiretroviral therapy (ART) for individuals in Arkansas, an Ending the HIV Epidemic (EHE) jurisdiction. This work involves a pharmacist-led program designed to improve access to and uptake of LAI ART. Moore has published three works, with an h-index of 1 and a total of 3 citations. Collaborations include shared publications with Jure Baloh and S. Alexandra Marshall from the University of Arkansas for Medical Sciences, as well as Gabriella Douglass and Elma Abdullah from Harding University Main Campus.
Metrics
- h-index: 1
- Publications: 3
- Citations: 3
Selected Publications
-
P-340. Adaptation of a Pharmacist-Led Long-Acting Injectable (LAI) Antiretroviral Therapy (ART) Program to Increase Use of LAI ART in Arkansas, an Ending the HIV Epidemic (EHE) Jurisdiction (2026)
Collaboration Network
Top Collaborators
- P-340. Adaptation of a Pharmacist-Led Long-Acting Injectable (LAI) Antiretroviral Therapy (ART) Program to Increase Use of LAI ART in Arkansas, an Ending the HIV Epidemic (EHE) Jurisdiction
- P-340. Adaptation of a Pharmacist-Led Long-Acting Injectable (LAI) Antiretroviral Therapy (ART) Program to Increase Use of LAI ART in Arkansas, an Ending the HIV Epidemic (EHE) Jurisdiction
- P-340. Adaptation of a Pharmacist-Led Long-Acting Injectable (LAI) Antiretroviral Therapy (ART) Program to Increase Use of LAI ART in Arkansas, an Ending the HIV Epidemic (EHE) Jurisdiction
- P-340. Adaptation of a Pharmacist-Led Long-Acting Injectable (LAI) Antiretroviral Therapy (ART) Program to Increase Use of LAI ART in Arkansas, an Ending the HIV Epidemic (EHE) Jurisdiction
- P-340. Adaptation of a Pharmacist-Led Long-Acting Injectable (LAI) Antiretroviral Therapy (ART) Program to Increase Use of LAI ART in Arkansas, an Ending the HIV Epidemic (EHE) Jurisdiction
- P-340. Adaptation of a Pharmacist-Led Long-Acting Injectable (LAI) Antiretroviral Therapy (ART) Program to Increase Use of LAI ART in Arkansas, an Ending the HIV Epidemic (EHE) Jurisdiction
- P-340. Adaptation of a Pharmacist-Led Long-Acting Injectable (LAI) Antiretroviral Therapy (ART) Program to Increase Use of LAI ART in Arkansas, an Ending the HIV Epidemic (EHE) Jurisdiction
- P-340. Adaptation of a Pharmacist-Led Long-Acting Injectable (LAI) Antiretroviral Therapy (ART) Program to Increase Use of LAI ART in Arkansas, an Ending the HIV Epidemic (EHE) Jurisdiction
- P-340. Adaptation of a Pharmacist-Led Long-Acting Injectable (LAI) Antiretroviral Therapy (ART) Program to Increase Use of LAI ART in Arkansas, an Ending the HIV Epidemic (EHE) Jurisdiction
- P-340. Adaptation of a Pharmacist-Led Long-Acting Injectable (LAI) Antiretroviral Therapy (ART) Program to Increase Use of LAI ART in Arkansas, an Ending the HIV Epidemic (EHE) Jurisdiction
Similar Researchers
Based on overlapping research topics